T. Klenner
Impact in
- Toxicology top 10%
-
- Bone health and treatments
- Metal complexes synthesis and properties
Papers in
- Oncology 8
- Bone health and treatments 4
- Cancer-related Molecular Pathways 2
- Co-authors
- David T. Hart (2 shared papers)Thomas Beckers (4 shared papers)B Nickel (2 shared papers)Peter Emig (2 shared papers)Gerald Bacher (2 shared papers)Norton Heise (1 shared paper)Fred R. Opperdoes (1 shared paper)D. Schmähl (5 shared papers)
- Journals
- Journal of Cancer Research and Clinical Oncology (3 papers)Laboratory Animals (2 papers)Advances in experimental medicine and biology (2 papers)Nuclear Medicine and Biology (1 paper)Clinical & Experimental Metastasis (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
T. Klenner
24 papers receiving 667 citations
Peers
Comparison fields: 5 of 80
- Toxicology 26
- Oncology 191
- Public Health, Environmental and Occupational Health 183
- Organic Chemistry 205
- Parasitology 36
Countries citing papers authored by T. Klenner
This map shows the geographic impact of T. Klenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Klenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Klenner more than expected).
Fields of papers citing papers by T. Klenner
This network shows the impact of papers produced by T. Klenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Klenner. The network helps show where T. Klenner may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Klenner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. | 2001 | 131 |
| 2 | 2000 | 114 | |
| 3 | 2001 | 58 | |
| 4 | 1999 | 52 | |
| 5 | 1990 | 50 | |
| 6 | 1990 | 48 | |
| 7 | 2001 | 48 | |
| 8 | 1996 | 44 | |
| 9 | Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase. | 1996 | 26 |
| 10 | 2001 | 21 | |
| 11 | 2000 | 19 | |
| 12 | 1997 | 12 | |
| 13 | 1990 | 11 | |
| 14 | 1994 | 11 | |
| 15 | 1988 | 11 | |
| 16 | 1990 | 9 | |
| 17 | 2001 | 8 | |
| 18 | 1989 | 7 | |
| 19 | 1990 | 5 | |
| 20 | Self-deleting suicide vectors (SDSV): selective killing of p53-deficient cancer cells. | 2001 | 5 |
About T. Klenner
T. Klenner is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry and Cancer Research, having authored 25 papers that have together received 707 indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), Trypanosoma species research and implications (3 papers), Organophosphorus compounds synthesis (3 papers), Research on Leishmaniasis Studies (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Medical Imaging and Pathology Studies (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Toxicology (26 citations), Oncology (191 citations), Public Health, Environmental and Occupational Health (183 citations), Organic Chemistry (205 citations) and Parasitology (36 citations). T. Klenner has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include David T. Hart, Thomas Beckers, B Nickel, Peter Emig, Gerald Bacher, Norton Heise, Fred R. Opperdoes, D. Schmähl, F. Wingen and Bernhard K. Keppler. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Laboratory Animals, Advances in experimental medicine and biology, Nuclear Medicine and Biology and Clinical & Experimental Metastasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.